Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 266 points (-2.0%) at 12,979 as of Wednesday, Nov. 7, 2012, 2:19 PM ET. The NYSE advances/declines ratio sits at 512 issues advancing vs. 2,488 declining with 87 unchanged. The Health Services industry currently sits down 1.6% versus the S&P 500, which is down 1.9%. On the negative front, top decliners within the industry include Humana ( HUM), down 7.6%, WellPoint ( WLP), down 5.0%, UnitedHealth Group ( UNH), down 3.5%, Life Technologies ( LIFE), down 3.3% and Becton Dickinson ( BDX), down 3.0%. A company within the industry that increased today was HCA Holdings ( HCA), up 8.4%. TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today: 5. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry lower today. As of noon trading, St Jude Medical is down $1.40 (-3.6%) to $37.30 on heavy volume Thus far, 3.2 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $37.21-$38.69 after having opened the day at $38.44 as compared to the previous trading day's close of $38.70. St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. St Jude Medical has a market cap of $12.2 billion and is part of the health care sector. The company has a P/E ratio of 14.6, below the S&P 500 P/E ratio of 17.7. Shares are up 12.9% year to date as of the close of trading on Tuesday. Currently there are 15 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 11 rate it a hold. TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full St Jude Medical Ratings Report now.